Contrast-enhanced magnetic resonance imaging (MS-325) in a murine model of systemic lupus erythematosus

Christoph U Herborn1, Ralph Waldschuetz, Thomas C Lauenstein

  • 1Department of Diagnostic and International Radiology, University Hospital Essen, Essen, Germany. christoph.herborn@uniessen.de

Abstract

Insights

Magnetic resonance imaging (MRI) with MS-325 effectively detected inflammation in Desoxyribonuclease I (Dnase1)-deficient mice, modeling systemic lupus erythematosus (SLE). This MRI technique shows promise for evaluating disease and potential therapies in SLE patients.

Area of Science:

  • Biomedical Imaging
  • Immunology
  • Animal Models of Disease

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by systemic inflammation.
  • Desoxyribonuclease I (Dnase1)-deficient mice exhibit symptoms mirroring human SLE.
  • Assessing inflammatory activity in SLE requires sensitive diagnostic tools.

Purpose of the Study:

  • To evaluate the utility of MRI with an intravascular contrast agent (MS-325) for detecting inflammatory activity.
  • To investigate MS-325 enhanced MRI in Dnase1-deficient mice as a model for SLE.
  • To correlate MRI findings with histopathological evidence of inflammation.

Main Methods:

  • Dnase1-deficient and normal mice (n=10 each) underwent MRI using MS-325 contrast agent on a 1.5 T scanner.
  • MR images focused on kidneys and aorta, with signal-to-noise ratios (SNR) measured pre- and post-contrast.
  • Image analysis was compared with histopathology findings.

Main Results:

  • Dnase1-knockout mice showed significant aortic wall and inhomogeneous renal enhancement.
  • Higher SNR values in knockout mice correlated with confirmed microscopic inflammatory changes (P < 0.05).
  • MS-325 enhanced MRI revealed inflammatory activity in the kidneys and vasculature.

Conclusions:

  • MS-325 enhanced MRI is a sensitive method for detecting renal and vascular inflammation in this SLE mouse model.
  • This imaging approach may aid in assessing therapeutic interventions for SLE.
  • MRI with MS-325 offers a potential tool for future clinical applications in SLE management.

Related Concept Videos